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Abstract
Background: The neuronal ceroid lipofuscinoses (NCL) are a heterogenous group of inherited
progressive neurodegenerative diseases in different mammalian species. Tibetan Terrier and Polish
Owczarek Nizinny (PON) dogs show rare late-onset NCL variants with autosomal recessive
inheritance, which can not be explained by mutations of known human NCL genes. These dog
breeds represent animal models for human late-onset NCL. In mice the chloride channel 3 gene
(Clcn3) encoding an intracellular chloride channel was described to cause a phenotype similar to
NCL.
Results: Two full-length cDNA splice variants of the canine CLCN3 gene are reported. The current
canine whole genome sequence assembly was used for gene structure analyses and revealed 13
coding CLCN3 exons in 52 kb of genomic sequence. Sequence analysis of the coding exons and
flanking intron regions of CLCN3 using six NCL-affected Tibetan terrier dogs and an NCL-affected
Polish Owczarek Nizinny (PON) dog, as well as eight healthy Tibetan terrier dogs revealed 13
SNPs. No consistent CLCN3 haplotype was associated with NCL.
Conclusion: For the examined animals we excluded the complete coding region and adjacent
intronic regions of canine CLCN3 to harbor disease-causing mutations. Therefore it seems to be
unlikely that a mutation in this gene is responsible for the late-onset NCL phenotype in these two
dog breeds.
Background
Neuronal ceroid lipofuscinoses (NCL) represents a group
of heritable neurodegenerative storage diseases in man,
mice, and several domestic animals like cattle, sheep,
goat, cat, and certain dog breeds [1]. NCL diseases are
characterized by the accumulation of autofluorescent
cytoplasmic storage bodies in cells of the brain and retina.
NCL diseases cause neurological symptoms that progress
relentlessly and culminate in a vegetative state in humans
and premature death [2]. Canine late-onset NCL variants
primarily affect Tibetan Terrier and Polish Owczarek
Nizinny (PON) dogs. A monogenic autosomal recessive
mode of transmission was suggested for those breeds
[3,4]. NCL-affected dogs represent valuable animal mod-
els to study human late-onset NCL variants since human
families segregating for adult NCL are infrequent. Human
NCL is a genetically heterogeneous disease with six iden-
tified disease genes (PPT1, TPP1, CLN3, CLN5, CLN6 and
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CLN8) [5]. Causal mutations within the canine orthologs
of the six known human NCL genes have not been identi-
fied in NCL-affected Tibetan Terrier and PON dogs [6-9].
Single point mutations in the coding regions of the canine
CLN8 and CLN5 genes were found in affected English Set-
ter and Border collie dogs, respectively, showing juvenile
NCL [6,10]. There are still undiscovered loci causing NCL
beside the six known human genes, as indicated by find-
ings in NCL-affected domestic and laboratory animals. In
White Swedish Landrace sheep a CTSD  mutation was
reported and a mutation within the ortholog canine CTSD
gene was detected in NCL-affected American Bulldogs
[11]. Recently, CTSD was excluded as candidate gene in
NCL-affected Tibetan Terrier and PON dogs [12]. In mice
the chloride channel 3 gene (Clcn3) encoding an intracel-
lular chloride channel was described to cause a phenotype
similar to NCL [13]. Clcn3-deficient mice are character-
ized by developmental retardation and higher mortality
combined with neurological manifestations such as
blindness, motor coordination deficit, and spontaneous
hyperlocomotion similar to human and canine NCL. To
evaluate whether the CLCN3 gene is involved in the NCL-
affected Tibetan Terrier and PON dogs, we determined the
full-length cDNA sequence, characterized the gene struc-
ture, and analyzed the coding sequence of the canine
ortholog.
Results and discussion
Sequence analysis
RT-PCR from canine lung mRNA amplified two splice var-
iants, which were verified by direct DNA-sequencing of
the RT-PCR products. Similar to the human CLCN3
sequence the alternative usage of exon 12 produces the
shorter CLCN3 and the longer CLCN3 isoform e, respec-
tively (Figure 1). Overlapping canine cDNA fragments
containing all junctions between the exons were gener-
ated by RT-PCR, sequenced, and used for comparison
with the genomic sequence. These analyses indicated that
the canine CLCN3 gene consists of 13 exons separated by
twelve introns. The canine CLCN3 gene spans 52 kb (Fig-
ure 1) compared to 14 exons over 100 kb in human
CLCN3 (NCBI build 35.1)) because in dog no untrans-
lated 5'-exon is used. All splice donor/splice acceptor sites
conform to the GT/AG rule. The experimentally verified
existence of the two alternative splice variants is in agree-
ment with the initially identified canine 5'-EST sequences
(Figure 1). In dog the shorter CLCN3  transcript
[EMBL:AM048629] contains an open reading frame of
Genomic structure of the canine CLCN3 gene Figure 1
Genomic structure of the canine CLCN3 gene. Translated exons are shown as solid boxes, untranslated regions of exons 
as shaded boxes. The two alternative gene transcripts are shown below.
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2,376 bp encoding a protein of 791 amino acids. The
longer canine CLCN3  isoform e transcript
[EMBL:AM048628] contains an open reading frame of
2,517 bp encoding a sequence of 838 amino acids.
Mutation analysis
A total of 13 sequence polymorphisms (Table 1) were
found in the examined dogs as compared to the CLCN3
reference sequence of the current dog genome assembly
(boxer genome assembly 1.1). The codon in exon 2 with
the A/G transition codes for glycine in both SNP variants
and the codon in exon 9 with the A/G transition codes for
proline in both SNP variants. None of the 11 intronic pol-
ymorphisms did affect splice sites in the CLCN3 gene. For
the single PON dog there were seven polymorphisms
compared to the Boxer reference sequence (Table 1).
Assuming linkage disequilibrium between the polymor-
phic loci six different haplotypes could be constructed for
the SNP genotypes in the Tibetan Terrier dogs (Table 1).
Four out of six haplotypes occurred in both, affected and
unaffected dogs, respectively (Table 2). Only the haplo-
types 3 and 4 occurred in a single heterozygous NCL-
affected Tibetan Terrier dog (Table 2). Due to the assump-
tion of a single recessive founder mutation within this
breed we expect homozygosity in affected individuals.
Table 2 summarizes the haplotype distribution among the
NCL-affected and the clinical unsuspicious dogs. The chi-
square statistic for testing these haplotypes for association
with disease status in the Tibetan Terrier dogs was calcu-
lated as 5.5786 with degree of freedom 1, which had a p-
value of 0.80, indicating no significant association.
Conclusion
The presented data indicate that the detected polymor-
phisms in the coding and adjacent intronic regions of
canine  CLCN3  can be excluded as disease harboring
mutations in the examined dogs. Therefore it seems to be
likely that the entire CLCN3 can be excluded as a candi-
date gene for the late-onset NCL phenotype in Tibetan
Terrier and PON dogs. As the candidate gene approach did
not reveal the causative gene in Tibetan Terrier and PON
dogs it might be indicated to perform a genome wide link-
age scan using NCL segregating families to map the canine
chromosome region harboring the deleterious gene.
Methods
Sequence analysis
The human reference CLCN3  mRNA [Gen-
Bank:NM_001829] was used as query in cross-species
BLAST searches against the dog genome assembly (Boxer
genome assembly 1.1). A single canine genomic contig of
577,638 bp was isolated [GenBank:AAEX01020012]. The
human mRNA sequence was used to identify putative
Table 1: Polymorphisms and observed haplotypes in the canine CLCN3 gene
Position1 Boxer2 Haplotype Tibetan Terrier PON
12345612
i n t r o n  1 1 6 4 0 9 TTTTTTTTC
e x o n  22AAAAAAGAA
intron 2 3 G A G G A G A G G
i n t r o n  5 1 0GAAAAAAAA
i n t r o n  6 4 0AAAAAAA d e l d e l
i n t r o n  6 2 8 6 1 TTTCCTTTT
i n t r o n  6 3 0 6 1 CGGGGGCGG
i n t r o n  6 3 2 6 6 GAAAAAGAA
intron 6 3270 G A G G A A A G G
i n t r o n  6 3 2 9 1 CTTTTTCTT
i n t r o n  7 3 8GGAGGGGGG
i n t r o n  7 1 4 4 CTCTTTTCC
e x o n  96AGGGGGGGG
1 Numbering refers to the position of the polymorphic nucleotide within the given exon or intron respectively.
2 Nucleotide refers to the publicly available dog genome sequence (AAEX01020012) from the boxer named Tasha.
Table 2: CLCN3 genotypes in NCL-affected and control dogs
Genotype Tibetan Terrier PON
1/1 1/2 3/4 1/5 1/6 1/2
NCL-affected (n) 4 1 1 1
NCL-non-affected 
(n)
51 11
1 Genotypes correspond to the deduced haplotypes shown in Table 1.BMC Genetics 2006, 7:13 http://www.biomedcentral.com/1471-2156/7/13
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exons in the canine genomic sequence used for dog spe-
cific RACE primer design. Total RNA from lung tissue of a
normal female Beagle (Biocat, Heidelberg, Germany) was
used for amplification of RACE PCR products. Isolation of
full length cDNA for the canine CLCN3 gene was achieved
by a modified rapid amplification of cDNA ends (RACE)
protocol with the FirstChoiceTM RNA ligase-mediated
(RLM)-RACE kit (Ambion Europe, Huntingdon, UK).
Briefly, in RLM-RACE uncapped RNAs were dephosphor-
ylated before the cap of full-length messenger RNAs
(mRNAs) was removed enzymatically. After this step an
RNA oligonucleotide adaptor was ligated to the 5'-end of
the decapped mRNAs. As only full-length RNAs carried a
5'-phosphate group, the adaptor was expected to ligate
exclusively to full-length mRNAs, while the dephosphor-
ylated other RNAs were not able to undergo a ligation
reaction. RT-PCR using two pairs of nested gene-specific
(Table 3) and adaptor-specific primer pairs (Ambion)
were then used to amplify the complete 5'-end of the
CLCN3 cDNA according to the instructions of the manu-
facturer. Similarly, the 3'-end was amplified using two
pairs of nested gene-specific and 3'-adaptor-specific prim-
ers. 5'- and 3'-RACE products and an additional 1885 bp
RT-PCR product using sense and antisense primers from
exon 1 and 10 (Table 3) were cloned into pDrive plasmid
vectors using the Qiagen PCR cloning kit (Qiagen, Hilden,
Germany) and several clones were sequenced. The
obtained canine cDNA sequences were aligned with par-
tially overlapping canine EST sequences corresponding to
the human CLCN3  [Gen-
Bank:BM537636,CF411209,BI398115,BU749098,BQ83
9554], and CLCN3  isoform e [GenBank:BM536915],
Table 3: Primer sequences for the amplification of canine CLCN3 cDNA
Primer Sequence (5' – 3') Localization within canine CLCN3 TM(°C)
5' RACE outer primer TGTACGAGCCAGGACCTTCT exon 4/exon 5 junction 60
5' RACE inner primer TTTGTCATTTCCCATGCTGA exon 2 60
3' RACE outer primer TGCTTTAGTGGCTGCATTTG exon 8 60
3' RACE inner primer TGACTGTCTCCCTGGTGGTT exon 10 60
CLCN3_F1 ATGGATGCTGCTTCTGATCC exon 1 60
CLCN3_R10 CAGCAGCCAGAGTGGTATGA exon 10 60
Table 4: Primer sequences for the amplification of canine CLCN3 exons
Forward primer Sequence (5' – 3') Reverse primer Sequence (5' – 3') TM(°C) Product size (bp)
CLCN3_Ex1_F AGCAGGGGTGGA
AGAAATG
CLCN3_Ex1_R AACTACAGAACCG
CCCAGC
60 233
CLCN3_Ex2_F ACCTAGTTCACCA
TTGTCTCTCA
CLCN3_Ex2_R TATTTTGGCTGCC
AGAGGTC
60 312
CLCN3_Ex3_F ACCCCTTGCTCTC
AAATCCT
CLCN3_Ex3_R TTGTAGGGTGAAG
GAGAGAACT
60 418
CLCN3_Ex4_F GTCTCAACACTCC
AAAAGTGGAC
CLCN3_Ex4_R CTGTAATTAAACG
GAGACTCATCTCA
60 321
CLCN3_Ex5_F TGTGGAAGTAAGC
CAAGAAACTC
CLCN3_Ex5_R CTCCCCCTAAAGG
CAAAAAG
60 318
CLCN3_Ex6_F AAGTGTTCCTGTT
TCCTGAATGA
CLCN3_Ex6_R GACTGAGCAGTAC
TGGGGATG
60 459
CLCN3_Ex7_F TTGGAAAGAGGTA
GCCATCG
CLCN3_Ex7_R GGCTTTTCTCAAG
GTAAAGAACAT
60 936
CLCN3_Ex8_F GCTGCAGCAAAAA
TTAGACCA
CLCN3_Ex8_R AAATGGAACCCAA
AAGATAAGAA
60 781
CLCN3_Ex9_F AGTTTTATTTGTAC
TAGGATTTTGCTC
CLCN3_Ex9_R CAATAGCAGTACT
GTTTCATTTCTGT
G
60 474
CLCN3_Ex10_F TCCTGTCCTCCTT
GACCAAT
CLCN3_Ex10_R CCCCCAGAAACCC
AACTAAT
60 579
CLCN3_Ex11_F GGGACCAAATTCA
TGGGATA
CLCN3_Ex11_R TGTTTTGGCAAAG
ATGTGGT
60 511
CLCN3_Ex12_F GGACCTGGGATTT
CGAACC
CLCN3_Ex12_R TTATTCAGCAGGC
ATCTGGG
60 343
CLCN3_Ex13_F ATCAAAGGATGGT
TGCTGGA
CLCN3_Ex13_R TTGCGATGTCGGA
GTAACAG
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respectively. The exact canine genomic structure was
determined using the mRNA-to-genomic alignment pro-
gram Spidey [14].
Mutation analysis
Genomic DNA was isolated from a single NCL-affected
PON dog, six unrelated NCL-affected Tibetan Terrier dogs,
and eight unrelated clinical unsuspicious Tibetan Terrier
dogs (> 8 years old). Clinical neurologic, behavioral, and
ophthalmologic evaluations were performed on each dog
by a single external consultant veterinarian [4,15]. The
phenotypes of the affected animals have been confirmed
by detection of autofluorescent cytoplasmic inclusions
within neurons throughout the retina and brain after
necropsy. The 13 CLCN3 exons with flanking sequences
were PCR amplified and directly sequenced with the
DYEnamic ET Terminator kit (Amersham Biosciences,
Freiburg, Germany) and a MegaBACE 1000 capillary
sequencer (Amersham Biosciences), using PCR primers
listed in table 4 as sequencing primers. The association
analysis for this paper was generated using SAS/HAPLO-
TYPE software, Version 2.1.39 of the SAS System for Win-
dows (2003 SAS Institute Inc., Cary, NC, USA).
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